A detailed history of Trust CO Of Vermont transactions in Eli Lilly & CO stock. As of the latest transaction made, Trust CO Of Vermont holds 8,117 shares of LLY stock, worth $6.65 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
8,117
Previous 8,288 2.06%
Holding current value
$6.65 Million
Previous $7.5 Million 4.16%
% of portfolio
0.36%
Previous 0.41%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

SELL
$772.14 - $960.02 $132,035 - $164,163
-171 Reduced 2.06%
8,117 $7.19 Million
Q2 2024

Jul 09, 2024

BUY
$724.87 - $909.04 $94,957 - $119,084
131 Added 1.61%
8,288 $7.5 Million
Q1 2024

May 03, 2024

BUY
$592.2 - $792.28 $723,668 - $968,166
1,222 Added 17.62%
8,157 $6.35 Million
Q4 2023

Mar 08, 2024

SELL
$525.19 - $619.13 $246,314 - $290,371
-469 Reduced 6.33%
6,935 $4.04 Million
Q3 2023

Nov 27, 2023

BUY
$434.7 - $599.3 $24,777 - $34,160
57 Added 0.78%
7,404 $3.98 Million
Q2 2023

Jul 17, 2023

SELL
$350.74 - $468.98 $14,731 - $19,697
-42 Reduced 0.57%
7,347 $3.45 Million
Q1 2023

Apr 07, 2023

SELL
$310.63 - $364.82 $28,888 - $33,928
-93 Reduced 1.24%
7,389 $2.54 Million
Q4 2022

Feb 09, 2023

BUY
$321.55 - $374.67 $94,214 - $109,778
293 Added 4.08%
7,482 $2.74 Million
Q3 2022

Oct 24, 2022

SELL
$296.48 - $337.87 $94,280 - $107,442
-318 Reduced 4.24%
7,189 $2.33 Million
Q2 2022

Jul 20, 2022

SELL
$278.73 - $327.27 $40,415 - $47,454
-145 Reduced 1.89%
7,507 $2.43 Million
Q1 2022

Apr 05, 2022

SELL
$234.69 - $291.66 $21,591 - $26,832
-92 Reduced 1.19%
7,652 $2.19 Million
Q4 2021

Jan 21, 2022

BUY
$224.85 - $279.04 $69,253 - $85,944
308 Added 4.14%
7,744 $2.14 Million
Q3 2021

Oct 22, 2021

SELL
$221.6 - $272.71 $32,575 - $40,088
-147 Reduced 1.94%
7,436 $1.72 Million
Q2 2021

Jul 15, 2021

BUY
$180.55 - $233.54 $3,069 - $3,970
17 Added 0.22%
7,583 $1.74 Million
Q1 2021

Apr 16, 2021

SELL
$164.32 - $212.72 $155,282 - $201,020
-945 Reduced 11.1%
7,566 $1.41 Million
Q3 2020

Nov 06, 2020

SELL
$146.22 - $169.13 $16,815 - $19,449
-115 Reduced 1.33%
8,511 $1.26 Million
Q2 2020

Jul 17, 2020

SELL
$136.42 - $164.18 $71,074 - $85,537
-521 Reduced 5.7%
8,626 $1.42 Million
Q1 2020

Apr 24, 2020

SELL
$119.05 - $147.35 $3,452 - $4,273
-29 Reduced 0.32%
9,147 $1.27 Million
Q4 2019

Feb 06, 2020

BUY
$106.92 - $132.43 $3,528 - $4,370
33 Added 0.36%
9,176 $1.21 Million
Q3 2019

Oct 24, 2019

SELL
$106.79 - $116.16 $14,737 - $16,030
-138 Reduced 1.49%
9,143 $1.02 Million
Q2 2019

Jul 26, 2019

SELL
$110.79 - $129.32 $6,204 - $7,241
-56 Reduced 0.6%
9,281 $1.03 Million
Q1 2019

May 01, 2019

SELL
$111.31 - $131.02 $22,150 - $26,072
-199 Reduced 2.09%
9,337 $1.21 Million
Q4 2018

Jan 30, 2019

SELL
$105.9 - $118.64 $9,848 - $11,033
-93 Reduced 0.97%
9,536 $1.1 Million
Q3 2018

Oct 26, 2018

SELL
$85.86 - $107.31 $6,782 - $8,477
-79 Reduced 0.81%
9,629 $1.03 Million
Q2 2018

Jul 11, 2018

BUY
$75.7 - $86.88 $67,600 - $77,583
893 Added 10.13%
9,708 $828,000
Q1 2018

May 18, 2018

SELL
$74.21 - $87.6 $14,545 - $17,169
-196 Reduced 2.18%
8,815 $682,000
Q4 2017

Feb 02, 2018

SELL
$81.94 - $87.89 $4,506 - $4,833
-55 Reduced 0.61%
9,011 $761,000
Q3 2017

Oct 24, 2017

BUY
$77.07 - $85.54 $698,716 - $775,505
9,066
9,066 $775,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $778B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Trust CO Of Vermont Portfolio

Follow Trust CO Of Vermont and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trust CO Of Vermont, based on Form 13F filings with the SEC.

News

Stay updated on Trust CO Of Vermont with notifications on news.